过度医疗行为认定及医保监管指标研究

郑树忠, 龚忆莼, 耿韬, 黄蛟灵

中国医疗保险 ›› 2022, Vol. 0 ›› Issue (12) : 23-28.

中国医疗保险 ›› 2022, Vol. 0 ›› Issue (12) : 23-28. DOI: 10.19546/j.issn.1674-3830.2022.12.004
专题分析

过度医疗行为认定及医保监管指标研究

  • 郑树忠1, 龚忆莼1, 耿韬2, 黄蛟灵3
作者信息 +

Research on the Confirmation of Medical Overuse Behavior and Medical Insurance Supervision Rules

Author information +
文章历史 +

摘要

过度医疗是医疗服务中长期存在的痼疾,“过度”存在着认知差异和模糊地带,以致在医保基金监管中易引起争议,存在界定难、识别难与处置难的现实困境。本文通过文献综述梳理过度医疗的内涵与边界,并以此为基础通过对医保监管文本资料与定点医疗机构监管过程中发现的过度医疗行为深入挖掘,形成过度医疗行为指标体系(5个一级指标、30个二级指标、67个三级指标),并以国际经验为借鉴,为优化、加强过度医疗医保监管规则提供建议与循证依据。

Abstract

Medical overuse is a persistent problem in medical insurance services. Differences in perception, interpretation of "overuse" lead to controversies in the supervision of medical insurance funds, it is difficult to define, identify, deal with overuse problems. This paper compares the connotation, boundary of medical overuse through a literature review. Based on this, we form a system of medical overuse indicators, including5first-level indicators, 30second-level indicators, 67third-level indicators, by digging deeper into the medical insurance supervision texts, the medical overuse behaviors seized during the supervision process of designated medical institutions. The system is based on international experience, provides suggestions, an evidence-based basis for optimizing, refining the application of medical overuse supervision rules

关键词

过度医疗 / 医保监管 / 指标体系

Key words

medical overuse / medical insurance supervision / indicator system

引用本文

导出引用
郑树忠, 龚忆莼, 耿韬, 黄蛟灵. 过度医疗行为认定及医保监管指标研究[J]. 中国医疗保险. 2022, 0(12): 23-28 https://doi.org/10.19546/j.issn.1674-3830.2022.12.004
Research on the Confirmation of Medical Overuse Behavior and Medical Insurance Supervision Rules[J]. China Health Insurance. 2022, 0(12): 23-28 https://doi.org/10.19546/j.issn.1674-3830.2022.12.004
中图分类号: F840.684    C913.7   

参考文献

[1] 崔新民,张红霞.医疗机构过度医疗行为监管难点及对策[J].人力资源管理, 2018, (7): 1.
[2] SPIEGEL A. More is Less [Z]. This American Life.2009. https://www.thisamericanlife.org/391/more-is-less.
[3] MCCUE M T.Clamping down on variation [Z]. Wayback Machine - Managed Healthcare Executive. 2007.
[4] HENSHER M, TISDELL J, ZIMITAT C.“Too much medicine”: Insights and explanations from economic theory and research[J]. Social science & medicine, 2017, 176: 77-84.
[5] REILLY B M, EVANS A T.Much ado about (doing) nothing[J]. Annals of internal medicine, 2009, 150(4): 270-1.
[6] FISHER E S, WENNBERG D E, STUKEL T A, et al.The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care[J]. Annals of internal medicine, 2003, 138(4): 288-98.
[7] SNYDER L, American College of Physicians Ethics P, Committee H R. American College of Physicians ethics manual[J]. Annals of internal medicine, 2012, 156(1_Part_2): 73-104.
[8] BERWICK D M, HACKBARTH A D.Eliminating waste in US health care[J]. Jama, 2012, 307(14): 1513-6.
[9] RALSTON S L, SCHROEDER A R.Doing more vs doing good: aligning our ethical principles from the personal to the societal[J]. JAMA pediatrics, 2015, 169(12): 1085-6.
[10] KLUG ENTSCHEIDEN [Z].KLUG ENTSCHEIDEN [Z]. Deutsche Gesellschaft für Innere Medizin e.V. 2022
[11] LEHMANN C, BERNER R, BOGNER J R, et al.The “Choosing Wisely” initiative in infectious diseases[J]. Infection, 2017, 45(3): 263-8.
[12] ODUNCU F S.Priority-setting, rationing and cost-effectiveness in the German health care system[J]. Medicine, Health Care and Philosophy, 2013, 16(3): 327-39.
[13] CARDONA-MORRELL M, KIM J, TURNER R M, et al.Non-beneficial treatments in hospital at the end of life: a systematic review on extent of the problem[J]. International Journal for Quality in Health Care, 2016, 28(4): 456-69.
[14] DRUML W, DRUML C.Overtreatment in intensive care medicine[J]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2019, 114(3): 194-201.

Accesses

Citation

Detail

段落导航
相关文章

/